Stock Market News2 weeks Johnson & Johnson makes $15 billion bet on mental-health drugs MarketWatch
Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.
Health · Johnson & Johnson (JNJ)
XPharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.
Health · Johnson & Johnson (JNJ)
X